Patient Monitoring
and Testing
Some monitoring is
manual (ie, by direct
observation and physical
examination) and
intermittent, with the
frequency depending on
the patient's illness.
This monitoring usually
includes measurement of
vital signs
(temperature, BP, pulse,
and respiration rate),
quantification of all
fluid intake and output,
and often daily weight.
BP may be recorded by an
automated
sphygmomanometer; many
of these devices also
incorporate a
transcutaneous sensor
for
pulse oximetry,
which is monitored as
well.
Other monitoring is
ongoing and continuous,
provided by complex
devices that require
special training and
experience. Most such
devices generate an
alarm if certain
physiologic parameters
are exceeded. Every ICU
should strictly follow
protocols for
investigating alarms.
Blood Tests
Although frequent blood
draws can destroy veins,
cause pain, and lead to
anemia, ICU patients
typically have routine
daily blood tests to
help detect problems
early. Generally,
patients need a daily
set of electrolytes and
a CBC. Patients with
arrhythmias should also
have Mg, phosphate, and
Ca levels. Patients on
TPN need weekly liver
enzymes and coagulation
profiles. Other tests
are done as needed (eg,
blood culture for fever,
CBC after bleeding
episode).
Point-of-care testing
uses miniaturized,
highly automated devices
to perform certain blood
tests at the patient's
bedside or unit
(particularly ICU,
emergency department,
and operating room).
Commonly available tests
include blood
chemistries, glucose,
ABGs, CBC, cardiac
markers, and coagulation
tests. Many are
performed in
<
2 min and require
<
0.5 mL blood.
Cardiac Monitoring
Most critical care
patients have cardiac
activity monitored by a
3-lead system; signals
are usually sent to a
central monitoring
station by a small radio
transmitter worn by the
patient. Automated
systems generate alarms
for abnormal rates and
rhythms and store
abnormal tracings for
subsequent review.
Some specialized cardiac
monitors track advanced
parameters associated
with coronary ischemia,
although their clinical
benefit is unclear.
These include continuous
ST segment monitoring
and heart rate
variability. Loss of
normal beat-to-beat
variability signals a
reduction in autonomic
activity and possibly
coronary ischemia and
increased risk of death.
Pulmonary Artery
Catheter Monitoring
Use of a pulmonary
artery catheter (PAC) is
common in ICU patients.
This device is a
balloon-tipped,
flow-directed catheter
that is inserted via
central veins through
the right side of the
heart into the pulmonary
artery. The catheter
typically contains
several ports that can
monitor pressure or
inject fluids. Some PACs
also include a sensor to
measure central (mixed)
venous O2
saturation. Data from
PACs are used mainly to
determine cardiac output
and preload. Preload is
most commonly estimated
by the pulmonary artery
occlusion pressure (PAOP)
However,
preload may be more
accurately determined by
right ventricular
end-diastolic volume,
which is measured
through the use of
fast-response
thermistors gated to
heart rate.
Despite widespread use,
PACs have not been shown
to reduce morbidity and
mortality. Indeed, PAC
use has been associated
with excess mortality.
This finding may be
explained by
complications of PAC use
and misinterpretation of
the data obtained.
Nevertheless, most
physicians believe PACs
aid in the management of
certain critically ill
patients when combined
with other objective and
clinical data. As with
many physiologic
measurements, a changing
trend is typically more
significant than a
single abnormal value.
Possible indications for
PACs are listed in Table
1)
|
Table 1
 |
|
Potential
Indications
for
Pulmonary
Artery
Catheterization |
|
Cardiac
disorders |
Acute
valvular
regurgitation
|
|
|
Complicated
heart
failure
|
|
|
Ventricular
septal
rupture
|
|
Hemodynamic
instability* |
Assessment
of
volume
status
|
|
Shock |
|
|
|
|
Postoperative
care
in
critically
ill
patients
|
Surgery
and
postoperative
care
in
patients
with
significant
heart
disease
|
|
Pulmonary
disorders |
Complicated
pulmonary
embolism
|
|
|
|
*Particularly
if
inotropic
drugs
required. |
|
Procedure:
The PAC is inserted
through the subclavian
or internal jugular vein
with the balloon
deflated. Once the
catheter tip reaches the
superior vena cava,
partial inflation of the
balloon permits blood
flow to guide the
catheter. The position
of the catheter tip is
usually determined by
pressure monitoring (see
Table 2) for
intracardiac and great
vessel pressures) or
occasionally by
fluoroscopy. Entry into
the right ventricle is
indicated by a sudden
increase in systolic
pressure to about 30 mm
Hg; diastolic pressure
remains unchanged from
right atrial or vena
caval pressure. When the
catheter enters the
pulmonary artery, the
systolic pressure does
not change, but
diastolic pressure rises
above right ventricular
end-diastolic pressure
or central venous
pressure (CVP), ie, the
pulse pressure narrows.
Further movement of the
catheter wedges the
balloon in a distal
pulmonary artery. A
chest x-ray confirms
proper placement.
|
Table 2
 |
|
Normal
Pressures
in the
Heart
and
Great
Vessels |
|
Type of
Pressure
|
Average
(mm Hg)
|
Range
(mm Hg)
|
|
Right
atrium |
3 |
0每8 |
|
Right
ventricle |
|
|
|
|
25 |
15每30 |
|
|
4 |
0每8 |
|
Pulmonary
artery |
|
|
|
|
15 |
9每16 |
|
|
25 |
15每30 |
|
|
9 |
4每14 |
|
Pulmonary
artery
occlusion |
|
|
|
|
9 |
2每12 |
|
Left
atrium |
|
|
|
|
8 |
2每12 |
|
|
10 |
4每16 |
|
|
13 |
6每12 |
|
Left
ventricle |
|
|
|
|
130 |
90每140 |
|
|
9 |
5每12 |
|
Brachial
artery |
|
|
|
|
85 |
70每150 |
|
|
130 |
90每140 |
|
|
70 |
60每90 |
|
Adapted
from
Fowler
NO:
Cardiac
Diagnosis
and
Treatment,
ed 3.
Philadelphia,
JB
Lippincott,
1980, p.
11. |
|
The systolic pressure
(normal, 15 to 30 mm Hg)
and diastolic pressure
(normal, 5 to 13 mm Hg)
are recorded with the
catheter balloon
deflated. The diastolic
pressure corresponds
well to the occlusion
pressure, although
diastolic pressure can
exceed occlusion
pressure when pulmonary
vascular resistance is
elevated secondary to
primary pulmonary
disease (eg, pulmonary
fibrosis, pulmonary
hypertension).
More..